| Item type |
学術雑誌論文 / Journal Article(1) |
| 公開日 |
2021-11-12 |
| タイトル |
|
|
タイトル |
A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-tomoderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial |
|
言語 |
en |
| 言語 |
|
|
言語 |
eng |
| 主題 |
|
|
主題Scheme |
Other |
|
主題 |
COVID-19 |
| 主題 |
|
|
主題Scheme |
Other |
|
主題 |
Randomized controlled trial |
| 主題 |
|
|
主題Scheme |
Other |
|
主題 |
Protocol |
| 主題 |
|
|
主題Scheme |
Other |
|
主題 |
Kampo medicines |
| 主題 |
|
|
主題Scheme |
Other |
|
主題 |
Symptom relief |
| 主題 |
|
|
主題Scheme |
Other |
|
主題 |
Prevention for severe stage |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| アクセス権 |
|
|
アクセス権 |
open access |
|
アクセス権URI |
http://purl.org/coar/access_right/c_abf2 |
| 作成者 |
Takayama, Shin
Namiki, Takao
Ito, Takashi
Arita, Ryutaro
Nakae, Hajime
Kobayashi, Seiichi
Yoshino, Tetsuhiro
Ishigami, Tomoaki
Tanaka, Koichiro
Kainuma, Mosaburo
Nochioka, Kotaro
Takagi, Airi
Mimura, Masaru
Yamaguchi, Takuhiro
Ishii, Tadashi
|
| 出版タイプ |
|
|
出版タイプ |
VoR |
|
出版タイプResource |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| 書誌情報 |
Trials
巻 21,
号 827,
発行日 2020
|
| 収録物識別子 |
|
|
収録物識別子タイプ |
EISSN |
|
収録物識別子 |
1745-6215 |
| 出版者 |
|
|
出版者 |
BMC |
| 関連情報 |
|
|
関連タイプ |
isIdenticalTo |
|
|
識別子タイプ |
DOI |
|
|
関連識別子 |
https://doi.org/10.1186/s13063-020-04746-9 |
| 権利情報 |
|
|
権利情報 |
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
iA_2021_20 (453.3 kB)
